Physician profile
Amber Scott
NPI 1790272268
$839.95
in general payments reported to CMS, 2019-2025
13 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $431 · 2022: $140 · 2023: $75.05 · 2024: $58.49 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $248.07 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $113.68 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $82.52 | 2021 | |
| Smith+Nephew, INC. | $82.37 | 2023-2025 | Renasys Go V2 Home, Collagenase Santyl, Pico 7 |
| Alkermes, INC. | $67.92 | 2021 | |
| Organogenesis INC. | $62.53 | 2023-2024 | Puraply |
| Sunovion Pharmaceuticals INC. | $54.60 | 2021 | |
| Jazz Pharmaceuticals INC. | $25.61 | 2024 | |
| Urgo Medical North America, LLC | $24.15 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Mannkind Corporation | $22.63 | 2022 | |
| Sk Life Science, INC. | $22.23 | 2025 | |
| Solventum Corporation | $18.32 | 2025 | Activ.A.C. |
| Ucb, INC. | $15.32 | 2024 | Nayzilam |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.